Download presentation
Presentation is loading. Please wait.
1
DOI: 10.1016/j.atherosclerosis.2016.04.017
Influences on plasminogen activator inhibitor-2 polymorphism-associated recurrent cardiovascular disease risk in patients with high HDL cholesterol and inflammation James P. Corsetti, Peter Salzman, Dan Ryan, Arthur J. Moss, Wojciech Zareba, Charles E. Sparks Atherosclerosis Volume 250, Pages 1-8 (July 2016) DOI: /j.atherosclerosis Copyright © 2016 Elsevier Ireland Ltd Terms and Conditions
2
Fig. 1 Subgraphs of Bayesian networks delineating direct forebears of outcome up to the grandparent level for (A) BN1, (B) BN2, and (C) BN3. Genetic polymorphism variables are indicated by an asterisk (multiple asterisks indicate position of the polymorphism in Table 2). Atherosclerosis , 1-8DOI: ( /j.atherosclerosis ) Copyright © 2016 Elsevier Ireland Ltd Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.